These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 33716096)

  • 21. A Laboratory Medicine Best Practices Systematic Review and Meta-analysis of Nucleic Acid Amplification Tests (NAATs) and Algorithms Including NAATs for the Diagnosis of
    Kraft CS; Parrott JS; Cornish NE; Rubinstein ML; Weissfeld AS; McNult P; Nachamkin I; Humphries RM; Kirn TJ; Dien Bard J; Lutgring JD; Gullett JC; Bittencourt CE; Benson S; Bobenchik AM; Sautter RL; Baselski V; Atlas MC; Marlowe EM; Miller NS; Fischer M; Richter SS; Gilligan P; Snyder JW
    Clin Microbiol Rev; 2019 Jun; 32(3):. PubMed ID: 31142497
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clostridioides difficile Infection in Cancer and Immunocompromised Patients: Relevance of a Two-step Diagnostic Algorithm and Infecting Ribotypes on Clinical Outcomes.
    Yepez Guevara EA; Aitken SL; Olvera AV; Carlin L; Fernandes KE; Bhatti MM; Garey KW; Adachi J; Okhuysen PC
    Clin Infect Dis; 2021 May; 72(10):e460-e465. PubMed ID: 32803229
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Host Immune Markers Distinguish Clostridioides difficile Infection From Asymptomatic Carriage and Non-C. difficile Diarrhea.
    Kelly CP; Chen X; Williams D; Xu H; Cuddemi CA; Daugherty K; Barrett C; Miller M; Foussadier A; Lantz A; Banz A; Pollock NR
    Clin Infect Dis; 2020 Mar; 70(6):1083-1093. PubMed ID: 31211839
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors affecting reported Clostridioides difficile infection rates; the more you look the more you find, but should you believe what you see?
    Davies K; Davis G; Barbut F; Eckert C; Petrosillo N; Pisapia R; Gärtner B; Berger FK; Reigadas E; Bouza E; Demont C; Wilcox MH
    Anaerobe; 2020 Apr; 62():102178. PubMed ID: 32092415
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of molecular testing on reported
    Ilieş I; Benneyan JC; Jabur TBC; Baker AW; Anderson DJ
    Infect Control Hosp Epidemiol; 2020 Mar; 41(3):306-312. PubMed ID: 31852562
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Description of antibiotic treatment in adults tested for Clostridioides difficile infection: a single-center case-control study.
    Kim MH; Kim YC; Kim JL; Park YS; Kim H
    BMC Infect Dis; 2022 Jan; 22(1):104. PubMed ID: 35093016
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Substantial reduction of healthcare facility-onset Clostridioides difficile infection (HO-CDI) rates after conversion of a hospital for exclusive treatment of COVID-19 patients.
    Ochoa-Hein E; Rajme-López S; Rodríguez-Aldama JC; Huertas-Jiménez MA; Chávez-Ríos AR; de Paz-García R; Haro-Osnaya A; González-Colín KK; González-González R; González-Lara MF; Ponce-de-León A; Galindo-Fraga A
    Am J Infect Control; 2021 Jul; 49(7):966-968. PubMed ID: 33352250
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterizing
    Magro M; Rosenberg J; Epson E
    Infect Control Hosp Epidemiol; 2021 Mar; 42(3):292-297. PubMed ID: 32993820
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of glutamate dehydrogenase (GDH) and toxin A/B rapid tests for Clostridioides (prev. Clostridium) difficile diagnosis in a university hospital in Minas Gerais, Brazil.
    Ramos CP; Lopes EO; Diniz AN; Lobato FCF; Vilela EG; Silva ROS
    Braz J Microbiol; 2020 Sep; 51(3):1139-1143. PubMed ID: 32367261
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multicenter Prevalence Study Comparing Molecular and Toxin Assays for Clostridioides difficile Surveillance, Switzerland.
    Widmer AF; Frei R; Kuijper EJ; Wilcox MH; Schindler R; Spaniol V; Goldenberger D; Egli A; Tschudin-Sutter S
    Emerg Infect Dis; 2020 Oct; 26(10):2370-2377. PubMed ID: 32946368
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Implementation of the Targeted Assessment for Prevention Strategy in a healthcare system to reduce
    White KA; Soe MM; Osborn A; Walling C; Fike LV; Gould CV; Kuhar DT; Edwards JR; Cochran RL
    Infect Control Hosp Epidemiol; 2020 Mar; 41(3):295-301. PubMed ID: 31928537
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Two-step Testing for Clostridioides Difficile is Inadequate in Differentiating Infection From Colonization in Children.
    Parnell JM; Fazili I; Bloch SC; Lacy DB; Garcia-Lopez VA; Bernard R; Skaar EP; Edwards KM; Nicholson MR
    J Pediatr Gastroenterol Nutr; 2021 Mar; 72(3):378-383. PubMed ID: 32925555
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discordant
    Lenggenhager L; Zanella MC; Poncet A; Kaiser L; Schrenzel J
    BMJ Open; 2020 Sep; 10(9):e036342. PubMed ID: 32928850
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preventable Patient Harm: a Multidisciplinary, Bundled Approach to Reducing Clostridium difficile Infections While Using a Glutamate Dehydrogenase/Toxin Immunochromatographic Assay/Nucleic Acid Amplification Test Diagnostic Algorithm.
    Schultz K; Sickbert-Bennett E; Marx A; Weber DJ; DiBiase LM; Campbell-Bright S; Bode LE; Baker M; Belhorn T; Buchanan M; Goldbach S; Harden J; Hoke E; Huenniger B; Juliano JJ; Langston M; Ritchie H; Rutala WA; Smith J; Summerlin-Long S; Teal L; Gilligan P
    J Clin Microbiol; 2018 Sep; 56(9):. PubMed ID: 29997201
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of Federal Value-Based Incentive Programs and In-Hospital Clostridioides difficile Infection Rates.
    Alrawashdeh M; Rhee C; Hsu H; Wang R; Horan K; Lee GM
    JAMA Netw Open; 2021 Oct; 4(10):e2132114. PubMed ID: 34714336
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnosis and treatment of Clostridioides difficile infection.
    Mateu L; Fernández-Rivas G; Sopena N
    Med Clin (Barc); 2020 Jul; 155(1):30-35. PubMed ID: 32430207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trends in U.S. Burden of
    Guh AY; Mu Y; Winston LG; Johnston H; Olson D; Farley MM; Wilson LE; Holzbauer SM; Phipps EC; Dumyati GK; Beldavs ZG; Kainer MA; Karlsson M; Gerding DN; McDonald LC;
    N Engl J Med; 2020 Apr; 382(14):1320-1330. PubMed ID: 32242357
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mitigating hospital-onset
    Carling PC; O'Hara LM; Harris AD; Olmsted R
    Infect Control Hosp Epidemiol; 2023 Mar; 44(3):440-446. PubMed ID: 35718355
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical significance of a positive Clostridioides difficile glutamate dehydrogenase test on the outcomes of hospitalized older patients.
    Nagayoshi Y; Yamamoto K; Sato S; Suyama N; Izumikawa T; Izumikawa K; Miyazaki T; Izumikawa K; Yanagihara K; Mukae H
    Geriatr Gerontol Int; 2020 Dec; 20(12):1138-1144. PubMed ID: 33098238
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clostridioides (Clostridium) difficile-associated disease: Epidemiology among patients in a general hospital in Saudi Arabia.
    Al-Tawfiq JA; Rabaan AA; Bazzi AM; Raza S; Noureen M
    Am J Infect Control; 2020 Oct; 48(10):1152-1157. PubMed ID: 32122671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.